1. Long-term outcomes following stereotactic body radiotherapy boost for oropharyngeal squamous cell carcinoma
- Author
-
Gerda M. Verduijn, Joost J. Nuyttens, Senada Koljenović, Hetty Mast, Aniel Sewnaik, W. Heemsbergen, Steven F. Petit, Sarah Baker, Radiotherapy, Otorhinolaryngology and Head and Neck Surgery, Oral and Maxillofacial Surgery, and Pathology
- Subjects
Adult ,Male ,medicine.medical_specialty ,Radiosurgery ,030218 nuclear medicine & medical imaging ,03 medical and health sciences ,0302 clinical medicine ,Long term outcomes ,Carcinoma ,medicine ,Humans ,Radiology, Nuclear Medicine and imaging ,Oropharyngeal squamous cell carcinoma ,Survival rate ,Aged ,Retrospective Studies ,Aged, 80 and over ,business.industry ,Dose fractionation ,Retrospective cohort study ,Hematology ,General Medicine ,Middle Aged ,Prognosis ,medicine.disease ,Survival Rate ,First line treatment ,Oropharyngeal Neoplasms ,Oncology ,030220 oncology & carcinogenesis ,Carcinoma, Squamous Cell ,Female ,Dose Fractionation, Radiation ,Radiology ,business ,Stereotactic body radiotherapy ,Follow-Up Studies - Abstract
Background/purpose: To determine the efficacy and toxicity profile of a stereotactic body radiotherapy (SBRT) boost as a first line treatment in patients with oropharyngeal squamous cell carcinoma ...
- Published
- 2019
- Full Text
- View/download PDF